At the summit in the Gulf of Corbis, the G7 nations engaged themselves in the 1 + 1 program: one billion vaccines should be delivered to poorer countries this year (very cheaply or donated) and one billion next year.
While Europe has already donated about 100 million doses (including 60 million doses from France and 30 million doses from Germany), Great Britain and the United States have now begun distributing the vaccine. Initially they refused to export in order to provide for their own population.
So far, Europe has exported half of the vaccine produced on the continent, according to a spokesman for the European Commission: about 350 million vaccines were vaccinated in Europe, the same amount exported. Companies such as Biotech have already donated 100 million cans, negotiating with the EU Commission and promising to deliver 1.3 billion cans to the poorest countries at the lowest possible cost or to the most economically developed countries at the lowest possible price.
The G7 summit also highlights the controversy surrounding the release of the vaccine patent. In the final announcement, there should be a formula that manufacturers should be committed to intensifying cooperation with pharmaceutical companies in poor countries. Otherwise, issuing patents is the last option. Simply put: if you want to keep your patent, make sure the vaccines are delivered worldwide! This is an acceptable compromise for Germany, which has a number of patents for MRNA vaccines.
According to Bild, the EU will invest ில்லியன் 1 billion to build the infrastructure needed for vaccine production in Africa, where it will support the establishment of excise taxes. This is more than just overcoming corona infection. In the next few years, Biotech and other manufacturers in Africa will also want to make vaccines against malaria and tuberculosis. According to commission sources, the EU has already signed agreements with pharmaceutical companies worth 60 60 billion.
This is the last G7 summit with President Angela Merkel – and the first with US President Joe Biden (78). Accordingly, the tone and mood of the meeting of the seven leading Western industrial nations in Cornwall, England, were quite different from those under his predecessor, Donald Trump (74).
Great Britain’s Prime Minister Boris Johnson described the conversation with Pita as “like a breath of fresh air” on Thursday. There is talk of a new era in which the G7 wants to emerge stronger from the epidemic crisis.
Critics say one billion is not enough
UN Secretary-General Antonio Guterres welcomed the G7 initiative on vaccine donations, but stressed the need for more effort. “One billion is very welcome. But obviously we need more than that,” he said on the sidelines of the summit.
Companies claim that it is very important to establish pharmaceutical factories in the countries of the recipients. This includes the approval of patents for desirable vaccines. Chancellor Merkel, backed by Johnson, is reluctant to do so.
According to Ox Oxfam, the world needs it At least eleven billion cans To defeat the corona.
One by one, 2.3 billion vaccines have been made worldwide, a quarter of which are in the G7 countries. However, these make up only ten percent of the world’s population.
The business journal “Economist” also complains: Adequate efforts by the G7 states represent “an economic folly, moral failure and diplomatic catastrophe.”
Instead, the industrial world must pledge to cover the estimated $ 50 billion cost of vaccinating 70 percent of the world’s population.
Some aid companies seek to issue patents for desirable vaccines. Chancellor Merkel, backed by Johnson, is reluctant to do so.
The first meeting with Merkel-Fiden
Biden is expected to meet with Merkel in person.
On Friday, July 15, it was announced on Friday that Merkel would be back in the White House for the first time in more than three years. Due to that meeting in Washington, it was expected that there would only be a face-to-face meeting with Fiden at the G7 summit.
The British G7 presidency announced Saturday night that a group of major industrialized nations would like to adopt the “Health Declaration from the Gulf of Corbis” at their summit. It is planned to reduce the development of vaccines, treatment modalities and diagnoses for future diseases within 100 days.
China should oppose the anti-silk road project
The G7 will also announce on Saturday a global infrastructure plan to balance the Chinese Silk Road initiative, according to US government sources.
It is raising hundreds of billions of dollars in public and private money for investment in developing countries, a US government official said. Democrats have not yet offered an alternative to the Beijing Plan, which is characterized by stress and a lack of occupational safety and environmental standards.
At the G7 summit, the United States will also push for concrete action against forced labor in China. The final report of the meeting should also include criticisms of the People’s Republic.
With the launch of its new Silk Road infrastructure initiative in 2013, China wants to greatly expand its influence. As part of the multi-billion dollar project, more than 100 countries have already signed cooperation agreements with the People’s Republic for the construction of railways, roads and ports.
Apple, Google and Co. Should move into the line pincer
The White House also announced that support for the US proposal for a global minimum tax is expected at the summit. So big digital companies like Apple or Google will have to pay at least 15 percent taxes globally in the future. G7 finance ministers saw a breakthrough in this regard last week. In the next phase, the G20 states – a large group of leading and emerging economies – are to be brought on board.
The G7 includes the United States, Great Britain and Germany, France, Italy, Japan and Canada. Australia, South Korea, South Africa and India are also participating as hosts from Saturday afternoon. Due to the tense epidemic situation in the country, the Indian delegation is almost involved. Discussions should end Sunday with the final announcement.